Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Oct 20, 2003
filing date -
Nov 10, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention refers to the use of a strain of Lactobacillus in particular Lactobacillus plantarum 299 (DSM 6595) or Lactobacillus plantarum 299 v (DSM 9843), giving to rise or increased amounts of propionic acid or acetic acid in colon for the preparation of a medicament reducing the risk factors involved in the metabolic syndrome, especially increasing the level of HDL cholesterol in serum, and reducing the levels of LDL, insulin and leptin, as well as a high blood pressure.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully